Bio

Christopher is Co-Head of the Nordics and a Partner of Bridgepoint Europe responsible for its investment activity in the Nordic region. He is a member of the Technology Sector team. He joined Bridgepoint in 2007. He currently sits on the boards of Cherry, Diaverum and Vitamin Well. He has worked on a number of transactions including Vitamin Well, Cherry, Evac, Nordic Cinema Group, Trustly and Terveystalo. Prior to joining Bridgepoint he worked in the investment banking division of UBS in London where he was involved in a number of cross border transactions. Christopher has an MSc in Business Administration and Finance from Stockholm University, School of Business.